Research
Hormonal
Tirzepatide led to a greater reduction in median triglyceride levels compared with semaglutide.
Tirzepatide may be preferred for patients needing significant triglyceride reduction.
StrongSupportsmedium confidence
Tirzepatide led to a greater reduction in median triglyceride levels compared with semaglutide.
Why this rating
The study is a retrospective chart review involving a specific patient cohort.
Source
Comparative Analysis of Efficacy and Safety of the Glucagon-Like-Peptide-1 Receptor Agonists Tirzepatide and Semaglutide in Solid-Organ Transplant Recipients.
Omar El Khatib et al. · Experimental and Clinical Transplantation · 2026
cohort · n=73
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →